Trial Profile
Phase II Study of S-1 plus LV (1 week on and 1 week off) as First-line Treatment for Patients with metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Levofolinic acid
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 24 May 2016 New trial record